140 related articles for article (PubMed ID: 17503422)
1. Exploration of backbone space in foldamers containing alpha- and beta-amino acid residues: developing protease-resistant oligomers that bind tightly to the BH3-recognition cleft of Bcl-xL.
Sadowsky JD; Murray JK; Tomita Y; Gellman SH
Chembiochem; 2007 May; 8(8):903-16. PubMed ID: 17503422
[TBL] [Abstract][Full Text] [Related]
2. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
[TBL] [Abstract][Full Text] [Related]
3. Chimeric (alpha/beta + alpha)-peptide ligands for the BH3-recognition cleft of Bcl-XL: critical role of the molecular scaffold in protein surface recognition.
Sadowsky JD; Schmitt MA; Lee HS; Umezawa N; Wang S; Tomita Y; Gellman SH
J Am Chem Soc; 2005 Aug; 127(34):11966-8. PubMed ID: 16117535
[TBL] [Abstract][Full Text] [Related]
4. Exploration of structure--activity relationships among foldamer ligands for a specific protein binding site via parallel and split-and-mix library synthesis.
Murray JK; Sadowsky JD; Scalf M; Smith LM; Tomita Y; Gellman SH
J Comb Chem; 2008; 10(2):204-15. PubMed ID: 18275161
[TBL] [Abstract][Full Text] [Related]
5. Residue-Based Preorganization of BH3-Derived α/β-Peptides: Modulating Affinity, Selectivity and Proteolytic Susceptibility in α-Helix Mimics.
Peterson-Kaufman KJ; Haase HS; Boersma MD; Lee EF; Fairlie WD; Gellman SH
ACS Chem Biol; 2015 Jul; 10(7):1667-75. PubMed ID: 25946900
[TBL] [Abstract][Full Text] [Related]
6. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
Modi V; Lama D; Sankararamakrishnan R
J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: analogues of the Bim BH3 domain.
Boersma MD; Haase HS; Peterson-Kaufman KJ; Lee EF; Clarke OB; Colman PM; Smith BJ; Horne WS; Fairlie WD; Gellman SH
J Am Chem Soc; 2012 Jan; 134(1):315-23. PubMed ID: 22040025
[TBL] [Abstract][Full Text] [Related]
8. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD
J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929
[TBL] [Abstract][Full Text] [Related]
9. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft.
Zhang YH; Bhunia A; Wan KF; Lee MC; Chan SL; Yu VC; Mok YK
J Mol Biol; 2006 Dec; 364(3):536-49. PubMed ID: 17011577
[TBL] [Abstract][Full Text] [Related]
10. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
Sugaya M; Nishino N; Katoh A; Harada K
J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
[TBL] [Abstract][Full Text] [Related]
11. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein.
Feng Y; Zhang L; Hu T; Shen X; Ding J; Chen K; Jiang H; Liu D
Arch Biochem Biophys; 2009 Apr; 484(1):46-54. PubMed ID: 19161970
[TBL] [Abstract][Full Text] [Related]
12. Photocontrollable peptide-based switches target the anti-apoptotic protein Bcl-xL.
Kneissl S; Loveridge EJ; Williams C; Crump MP; Allemann RK
Chembiochem; 2008 Dec; 9(18):3046-54. PubMed ID: 19012295
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of Bcl-xL recognition by a BH3-mimetic α/β-peptide generated by sequence-based design.
Lee EF; Smith BJ; Horne WS; Mayer KN; Evangelista M; Colman PM; Gellman SH; Fairlie WD
Chembiochem; 2011 Sep; 12(13):2025-32. PubMed ID: 21744457
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of Bak derived peptides: affinity and specificity modulations by amino acid replacement.
Frey V; Viaud J; Subra G; Cauquil N; Guichou JF; Casara P; Grassy G; Chavanieu A
Eur J Med Chem; 2008 May; 43(5):966-72. PubMed ID: 17692431
[TBL] [Abstract][Full Text] [Related]
15. α/β-Peptide Foldamers Targeting Intracellular Protein-Protein Interactions with Activity in Living Cells.
Checco JW; Lee EF; Evangelista M; Sleebs NJ; Rogers K; Pettikiriarachchi A; Kershaw NJ; Eddinger GA; Belair DG; Wilson JL; Eller CH; Raines RT; Murphy WL; Smith BJ; Gellman SH; Fairlie WD
J Am Chem Soc; 2015 Sep; 137(35):11365-75. PubMed ID: 26317395
[TBL] [Abstract][Full Text] [Related]
16. Residue-based control of helix shape in beta-peptide oligomers.
Appella DH; Christianson LA; Klein DA; Powell DR; Huang X; Barchi JJ; Gellman SH
Nature; 1997 May; 387(6631):381-4. PubMed ID: 9163422
[TBL] [Abstract][Full Text] [Related]
17. Protein design with L- and D-alpha-amino acid structures as the alphabet.
Durani S
Acc Chem Res; 2008 Oct; 41(10):1301-8. PubMed ID: 18642934
[TBL] [Abstract][Full Text] [Related]
18. New helical foldamers: heterogeneous backbones with 1:2 and 2:1 alpha:beta-amino acid residue patterns.
Schmitt MA; Choi SH; Guzei IA; Gellman SH
J Am Chem Soc; 2006 Apr; 128(14):4538-9. PubMed ID: 16594667
[TBL] [Abstract][Full Text] [Related]
19. Alpha-aminoxy acids: new possibilities from foldamers to anion receptors and channels.
Li X; Wu YD; Yang D
Acc Chem Res; 2008 Oct; 41(10):1428-38. PubMed ID: 18785763
[TBL] [Abstract][Full Text] [Related]
20. The proteolytic stability and cytotoxicity studies of L-aspartic acid and L-diaminopropionic acid derived beta-peptides and a mixed alpha/beta-peptide.
Ahmed S; Kaur K
Chem Biol Drug Des; 2009 May; 73(5):545-52. PubMed ID: 19317848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
